AI assistant
Sending…
COLLEGIUM PHARMACEUTICAL, INC — Director's Dealing 2019
Jul 23, 2019
32163_dirs_2019-07-23_e34fbec9-fa19-4bc5-b766-b78ae2a8107c.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: COLLEGIUM PHARMACEUTICAL, INC (COLL)
CIK: 0001267565
Period of Report: 2019-07-19
Reporting Person: Brannelly Paul (Executive Vice President & CFO)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2019-07-19 | Common Stock | F | 181 | $10.35 | Disposed | 152107 | Direct |
Footnotes
F1: Shares withheld by the Issuer to satisfy applicable withholding taxes upon vesting of restricted stock units.
More from COLLEGIUM PHARMACEUTICAL, INC
Share Issue/Capital Change
2026
Jun 1
Regulatory Filings
2026
Jun 1
Regulatory Filings
2026
May 15
Regulatory Filings
2026
May 12
Interim / Quarterly Report
2026
May 7
Regulatory Filings
2026
May 7
Annual Report
2026
Apr 7
Proxy Solicitation & Information Statement
2026
Apr 7
Board/Management Information
2026
Apr 7
Major Shareholding Notification
2026
Mar 26